Boston Biotech Office, Filled 18 Months Before Completion, Shows Surging Demand
Switzerland-Based Gene Editing Firm Crispr Therapeutics Agrees to Take New Lab Space Near Seaport District Developers of one of the latest life-sciences office buildings to spring up in and around Boston’s Seaport District have landed a tenant 18 months before the project’s expected finish, reflecting demand in the nation’s largest biotech region.
Harvard taps Tishman Speyer to manage first phase of its new 36-acre research campus — and biotechs can’t wait
Tishman Speyer got the nod to lead the development of the first phase of Harvard’s new Enterprise Research Campus in Allston, which will be landing in the middle of one of the busiest biotech hubs in the world — where demand for new space is sky-high. And they’ll be supported by a partner with deep […]
Harvard Designates Tishman Speyer As Preferred Developer For Initial Phase Of Enterprise Research Campus In Allston
World Renowned Developer Prioritizes Public Realm, Place-Making, Sustainability, Diversity, Affordable Housing in Proposal BOSTON, Dec. 19, 2019 /PRNewswire/ — The Harvard Allston Land Company (HALC) has designated Tishman Speyer as the preferred developer for the initial phase of Harvard University’s Enterprise Research Campus (ERC) in Allston. Led by President and CEO Rob Speyer, Tishman Speyer is […]
Kite’s Belldegrun Launches Biotech-Focused Real Estate Company, Breakthrough Properties
Arie Belldegrun, founder and former chair, president and chief executive officer ofKite Pharma, has teamed up with real estate developer Tishman Speyer to launch a biotech-focused real estate company, Breakthrough Properties. Kite was acquired by Gilead Sciences in 2017 for $12 billion. Belldegrun’s family company, Bellco Capital, entered the joint venture and has bought its […]